Masatsugu Ueda
Comptroller/Controller/Auditor bij PHOENIXBIO CO., LTD.
Profiel
Masatsugu Ueda is currently working as an Auditor at PhoenixBio Co., Ltd.
He previously worked as a Managing Director at Institute of Immunology Co., Ltd.
and as an MD & Manager-Transgenic Animal Division at PhoenixBio Co., Ltd.
Actieve functies van Masatsugu Ueda
| Bedrijven | Functie | Begin |
|---|---|---|
| PHOENIXBIO CO., LTD. | Comptroller/Controller/Auditor | 01-06-2019 |
Eerdere bekende functies van Masatsugu Ueda
| Bedrijven | Functie | Einde |
|---|---|---|
Institute of Immunology Co., Ltd.
 Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Director/Board Member | - |
| PHOENIXBIO CO., LTD. | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PHOENIXBIO CO., LTD. | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
Institute of Immunology Co., Ltd.
Institute of Immunology Co., Ltd. Medical SpecialtiesHealth Technology Institute of Immunology Co., Ltd. engages in the manufacture and sale of diagnostic reagents and monoclonal antibodies for research purpose. It develops and produces Enzyme Immunoassay (EIA) kits related to infectious diseases such as hepatitis B as well as those for human hepatocellular growth factor determination. The firm also offers EIA kits for detecting hepatitis E virus antibody and for determining the genotypes of hepatitis B virus and offers immunization of 3 mice, evaluation, fusion, screening, cloning, ascites production and purification services to the research, clinical and medical industries. The company was founded by Tetsuo Nakamura on August 18, 1979 and is headquartered in Tokyo, Japan. | Health Technology |
